Tradestie Institutional Equity Comparison Engine

ANL vs PVLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PVLA Overall Edge

PVLA Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Options & Structure while ANL counters with relative strength in Momentum & Technical. Fundamentally, ANL trades at N/M Forward P/E with -123.5% operating margin (+178.1% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ANL N/M vs PVLA N/M Fwd P/E
Growth & Margin Winner PVLA
Op Margin -123.5% vs 0.0% ยท YoY +178.1% vs +0.0%
Momentum & Technical Winner ANL
1Y +560.3% vs +80.2% ยท 52W Pos 56% vs 68%
Options & Structure Winner PVLA
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (2nd %ile IV)
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
1M Return -9.61%
1Y Return +560.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.2 / 100 HOLD
Tech 35.0 Fund 53.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANL +560.26% PVLA +80.16% Spread: +480.1 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANL TTM Op. Margin: -123.5% PVLA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANL vs PVLA. Trailing 12-month operating profitability (ANL -123.5% vs PVLA 0.0%) and valuation multiples (ANL N/M vs PVLA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANL (2) vs PVLA (5)
Institutional Metric ANL PVLA Criterion Row Winner
Market Capitalization Scale $677.5M $2.2B Larger Scale PVLA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +178.1% +0.0% Higher Growth ANL
Operating Margin (TTM) Profitability -123.5% 0.0% Higher Margin PVLA
Net Profit Margin Profitability -124.8% 0.0% Higher Margin PVLA
Return on Equity (ROE) Capital Efficiency -20.2% -63.4% Higher ROE ANL
52-Week Range Position Momentum 56% ($1โ€“$17) 68% ($72โ€“$180) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 2.61ฮฒ ยท 79% Vol 1.66ฮฒ ยท 75% Vol Lower Realized Risk PVLA
Unified Institutional Score Composite Signal 48.3 / 100 (HOLD) 48.2 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANL vs PVLA Buy Guide
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANL nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.